Chitosan scaffold, concentrated growth factor and gingival mesenchymal stem cells as the osteoporotic jawbone therapy: A review

Fianza Rezkita and Andari Sarasati and Fadhilah N. Wijaya and Alexander Patera Nugraha and Nike Hendrijantini and Rini Devijanti Ridwan and Nastiti Faradilla Ramadhani and Amaq Fadholly and Arif Nur Muhammad Ansori and Raden Joko Kuncoroningrat Susilo (2020) Chitosan scaffold, concentrated growth factor and gingival mesenchymal stem cells as the osteoporotic jawbone therapy: A review. Biochemical and Cellular Archives, 20 (1). pp. 2913-2919. ISSN 09725075

[img] Text (ARTIKEL)

Download (102kB)
[img] Text (SIMILARITY)
10_Turnitin 21 Chitosan scaffold, concentrated growth factor.pdf

Download (2MB)
[img] Text (PEER REVIEW)
validasi 10.pdf

Download (610kB)


Osteoporosis affects the oral and maxillofacial parts which can cause an osteoporotic jawbone (OJB). Osteoporosis therapy can be through both surgical and non-surgical approaches. One of the effective and optimal alternative therapies needed for OJB therapy is, for example, the regenerative therapy. The concept of regenerative therapies involving the triad of tissue engineering such as cells, growth factors and biomaterials can be applied in OJB therapy by combining the injectable chitosan scaffold (ICS) as a biomaterial scaffold, concentrated growth factor (CGF) as a growth factor, and gingival mesenchymal stem cells (GMSCs) as medicinal signaling cells. The purpose of this review was to describe the future prospect of ICS, CGF, and GMSCs as regenerative osteoporotic jaw bone therapy. ICS is biocompatible and biodegradable and easy to apply. It has the osteoinductive, osteoconductive, and osteotemplate properties. While, GMSCs are chosen compared to other MSCs because they are easily available and proliferate faster than Bone Marrow-derived Stem Cells (BMSC) and Dental Pulp Stem Cells (DPSCs).Besides, CGF is picked because, it has more fibrin and growth factors (GF) than Platelet Rich Fibrin (PRF) and Platelet Rich Plasma (PRP). The combination of ICS, CGF and GMSC has the potential and promising therapy in treating OJB.

Item Type: Article
Uncontrolled Keywords: Medicine, concentrated growth factor, gingival mesenchymal stem cells, osteoporosis
Subjects: R Medicine
R Medicine > RK Dentistry
Divisions: 02. Fakultas Kedokteran Gigi > Oral Biology
Andari SarasatiNIM021611133146
Fadhilah N. WijayaUNSPECIFIED
Alexander Patera NugrahaNIM021111161
Nike HendrijantiniNIDN0006105908
Rini Devijanti RidwanNIDN0016126404
Nastiti Faradilla RamadhaniNIM021111106
Amaq FadhollyNIM061211131052
Arif Nur Muhammad AnsoriNIM081211433004
Raden Joko Kuncoroningrat SusiloNIM081714153012
Depositing User: Rudy Febiyanto
Date Deposited: 26 Oct 2020 01:56
Last Modified: 26 Oct 2020 01:56
Sosial Share:

Actions (login required)

View Item View Item